Top Section/Ad
Top Section/Ad
Most recent
Big deal joins light supply in January
Bankers say deals are still being launched and believe international rivalry can be negotiated
Banks accept some deals will bypass them — others they can intermediate
Sectors shape up as main sources of corporate syndicated lending demand amid renewed geopolitical uncertainty
More articles/Ad
More articles/Ad
More articles
-
AstraZeneca, the UK pharmaceuticals company, has lined up $17.5bn of bridge loans from three banks to back its $39bn acquisition of US biotech firm Alexion. -
Ahold Delhaize, the Dutch grocer, has refinanced a €1bn revolving credit facility and added sustainability-linked metrics to the deal, as the company’s capital structure continues its shift towards ecological and socially conscious financing.
-
Sanofi, the French pharmaceutical company, has signed €8bn of sustainability-linked syndicated loans, while Italian natural gas distribution company Ascopiave has completed its own deal using the structure.
-
The battle for the UK security firm G4S is entering its final phase, with initial hostile suitor GardaWorld potentially upping its offer after Allied Universal said it had agreed to buy the target company for £3.8bn.
-
Two Chinese borrowers, Beijing Construction Engineering Group and CPI Ronghe Financial Leasing, have closed syndication for their loans.
-
CPI Ronghe Financial Leasing, a subsidiary of Chinese state-owned State Power Investment Corp, has increased its loan size to $250m.
